Vistin Pharma ASA (OSL:VISTN)

Vistin Pharma ASA Balance Sheet

Financials in millions NOK. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.9	16.42	12.8	26.2	1.44	35.75
Cash & Short-Term Investments	7.9	16.42	12.8	26.2	1.44	35.75
Cash Growth	254.67%	28.31%	-51.17%	1726.06%	-95.99%	-53.60%
Accounts Receivable	96.22	89.71	44.28	47.02	66.16	40.25
Other Receivables	19.42	10.43	7.7	12.56	5.01	2.85
Receivables	115.64	100.14	51.97	59.59	71.17	43.09
Inventory	78.78	82.13	76.67	80.17	83.45	42.91
Prepaid Expenses	-	4.83	1.75	2.81	3.14	16.09
Other Current Assets	0	0	-	-	-	-
Total Current Assets	202.32	203.52	143.19	168.77	159.18	137.83
Property, Plant & Equipment	220.24	223.75	229.6	219.98	219.43	167.46
Long-Term Investments	12.15	12.15	12.15	-	-	-
Long-Term Deferred Tax Assets	-	-	-	14.64	28.6	27.86
Other Long-Term Assets	0	-	0	-	-	0
Total Assets	434.71	439.43	384.95	403.4	407.21	333.15

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	19.21	30.24	13.05	18.92	25.91	20.81
Accrued Expenses	-	14.82	15.82	16.59	14.67	16.58
Short-Term Debt	15.52	-	-	-	45.14	-
Current Portion of Leases	0.63	0.89	0.92	-	1.07	0.88
Current Income Taxes Payable	-	7.73	-	-	-	-
Other Current Liabilities	45.97	33.04	34.18	33.96	30.78	2.78
Total Current Liabilities	81.33	86.72	63.97	69.47	117.57	41.04
Long-Term Leases	0.17	0.62	1.33	-	2.96	0.51
Pension & Post-Retirement Benefits	6.2	6.42	6.6	8.86	13.2	15.83
Long-Term Deferred Tax Liabilities	26.91	16.86	3.52	-	-	-
Other Long-Term Liabilities	0	0	0	2.29	-0	0
Total Liabilities	114.62	110.62	75.42	80.63	133.73	57.38

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	44.35	44.35	44.35	44.35	44.35	44.35
Additional Paid-In Capital	29.52	73.87	129.3	206.89	206.89	206.89
Retained Earnings	246.23	210.6	135.89	71.54	22.26	24.54
Shareholders' Equity	320.1	328.81	309.53	322.77	273.49	275.77
Total Liabilities & Equity	434.71	439.43	384.95	403.4	407.21	333.15

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	16.32	1.51	2.24	-	49.17	1.39
Net Cash (Debt)	-8.43	14.91	10.55	26.2	-47.73	34.36
Net Cash Growth	-	41.28%	-59.73%	-	-	-55.40%
Net Cash Per Share	-0.19	0.34	0.24	0.59	-1.08	0.77
Filing Date Shares Outstanding	44.34	44.34	44.34	44.34	44.34	44.34
Total Common Shares Outstanding	44.34	44.34	44.34	44.34	44.34	44.34
Working Capital	120.99	116.8	79.22	99.3	41.61	96.8
Book Value Per Share	7.22	7.41	6.98	7.28	6.17	6.22
Tangible Book Value	320.1	328.81	309.53	322.77	273.49	275.77
Tangible Book Value Per Share	7.22	7.41	6.98	7.28	6.17	6.22
Machinery	-	281.31	268.64	263.53	253.37	-
Construction In Progress	-	39.32	39.09	17.91	10.24	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error